SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-033794
Filing Date
2023-06-02
Accepted
2023-06-02 16:33:03
Documents
2
Period of Report
2023-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4250
2 POA DOCUMENT poa.txt EX-24 3632
  Complete submission text file 0001209191-23-033794.txt   9311
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG. 1400 CAMBRIDGE MA 02139
Business Address
Beckman Daniella (Reporting) CIK: 0001513422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 23989425

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)